Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
NL0015436031
Mon, 19.04.2021
CureVac
CureVac Swiss AG Initiates Rolling Submission Process for mRNA-based COVID-19 Vaccine Candidate, CVnCoV, with Swissmedic
- Rolling submission to accelerate time to marketing authorization of CVnCoV in Switzerland
- Review process started with submission of first CVnCoV data package
TÜBINGEN, Germany/ BOSTON, USA - April 19, 2021 - The CureVac S [ … ]
Thu, 15.04.2021
CureVac
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
- COVID-19 vaccine candidate: CVnCoV in final stage of clinical development and believed to be well on track to provide data for conditional approval based on EMA rolling submission
- Pivotal Phase 2b/3 in Europe and Latin America fully recruited [ … ]
Fri, 09.04.2021
CureVac
CureVac to Report Fourth Quarter and Full-Year 2020 Financial Results and Business Updates on April 15, 2021
TÜBINGEN, Germany/ BOSTON, USA - April 9, 2021 - CureVac N.V. (Nasdaq: CVAC), a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), will report financial results and bus [ … ]